<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="be reduced and overall survival would increase. The effect of" exact="hydroxychloroquine" post="on hepatic tissue seems ambiguous, since it is used"/>
 <result pre="al. 2020). Furthermore, azithromycin-induced hepatotoxicity only appears 1â€“3 weeks after" exact="azithromycin" post="initiation (Martinez et al. 2015). Patients suffering either from"/>
 <result pre="(NAFLD). NAFLD can sensitize the liver for hepatotoxicants such as" exact="acetaminophen" post="(Michaut et al. 2014; Massart et al. 2017), which"/>
 <result pre="such as intake of steatosis-inducing drugs (e.g. sodium valproate, amiodarone," exact="tamoxifen" post="and methotrexate) (Boeckmans et al. 2018), could play a"/>
 <result pre="have been used to assess the pharmacological effects of remdesivir," exact="chloroquine" post="and hydroxychloroquine, all potential anti-COVID-19 treatments under study (Liu"/>
 <result pre="nonalcoholic fatty liver disease: friend or foe?Gastroenterology20161501704170910.1053/j.gastro.2016.01.02526826669 GautretPLagierJParolaPet al.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
 <result pre="injury using human hepatic cell systemsToxicol Lett2016240505910.1016/j.toxlet.2015.10.01426497421 WangMCaoRZhangLet al.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-NCoV) in"/>
</results>
